Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.020
-0.020 (-1.92%)
Jun 18, 2026, 2:04 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.11 billion as of June 17, 2026. Its market cap has decreased by -8.59% in one year.
Market Cap
2.11B
Enterprise Value
2.81B
Revenue
2.00B
Ranking
n/a
PE Ratio
40.50
Stock Price
1.02
Market Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.11B, a decrease of -68.64%. That is a compound annual growth rate of -15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.11B | 4.00% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 2.60B |
| PegBio | 2.51B |
| TYK Medicines | 2.48B |
| Viva Biotech Holdings | 2.39B |
| Beijing Luzhu Biotechnology | 2.39B |
| AIM Vaccine | 2.33B |
| Antengene Corporation | 2.24B |
| HighTide Therapeutics | 1.77B |